Intervention Review

You have free access to this content

Corticosteroids for acute traumatic brain injury

  1. Phil Alderson1,*,
  2. Ian Roberts2

Editorial Group: Cochrane Injuries Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 6 JAN 2008

DOI: 10.1002/14651858.CD000196.pub2

How to Cite

Alderson P, Roberts I. Corticosteroids for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD000196. DOI: 10.1002/14651858.CD000196.pub2.

Author Information

  1. 1

    National Institute for Health and Clinical Excellence, Manchester, UK

  2. 2

    London School of Hygiene & Tropical Medicine, Cochrane Injuries Group, London, UK

*Phil Alderson, National Institute for Health and Clinical Excellence, Level 1A, City Tower,, Piccadilly Plaza, Manchester, M1 4BD, UK. Philip.Alderson@nice.org.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

 
Characteristics of included studies [ordered by study ID]
Alexander 1972

MethodsPaper states that patients were randomized, half of them receiving dexamethasone.


ParticipantsThose admitted to hospital with acute non missile head injuries who responded to painful stimuli by withdrawal or rigidity but who would not respond to voice command.


Interventions
  1. Dexamethasone 10mg IV; then 4mg IM every 6 hours for 10 days.
  2. No steroid, no mention of placebo.


OutcomesDeath (time of assessment not stated).
Complications.


NotesStates all patients uniformly supervised.
Author contacted, no further details of trial available.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Braakman 1983

MethodsRandomized into two groups using identical vials in identical boxes prepared by a Pharmacy Department. Code not broken until all patients were evaluated for outcome.


ParticipantsPatients of any age with severe non missile related head injury who were in a coma on admission to hospital. Coma was defined as no eye opening, no spoken response to painful stimuli and not obeying commands. Exclusions were those already brain dead (apnoea, flaccidity, dilated pupils not reacting to light, absence of reflex eye movements) or expected to become so within 1 hour, those who regained consciousness during initial examination, those who had already been given steroids and those with diabetes mellitus or a history of peptic ulcer.


Interventions
  1. Dexamethasone phosphate: initial dose 100mg IV (less than 6 hours from injury), days 1 to 4 100mg/day IV, days 5 to 7 16mg/day IV or IM, day 8 12mg IV/IM, day 9 8mg IV/IM, day 10 4mg IV/IM.
  2. Placebo.


OutcomesGlasgow Coma Scale at 6 months after injury.
Complication rate.


NotesOther care was determined by the result of a CT scan: those with a mass lesion had immediate operation, those without had monitored control of intracranial pressure using controlled ventilation and/or osmotic diuretic. Cerebrospinal fluid was drained in some patients. Barbiturates were not used.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Braun 1986

MethodsPatients randomly assigned in emergency room to one of four groups.


ParticipantsThose head trauma victims admitted from the emergency room to the adult neurosurgical intensive care unit.


Interventions
  1. Dexamethasone 6mg/kg IV in the emergency room; then 6mg/kg IV 6 hourly for 1 day, then 1mg/kg IV 6 hourly for 4 days followed by a tapering dose.
  2. Dexamethasone 6mg/kg IV in the emergency room; then 0.1mg/kg IV 6 hourly for 5 days followed by a tapering dose.
  3. Dexamethasone 6mg/kg IV in the emergency room: single dose only.
  4. No steroids, no mention of placebo.


OutcomesIncidence of pneumonia defined as a new alveolar or alveolar-interstitial infiltrate identified by a radiologist and one of the authors and two of:

  1. Fever greater than 100F.
  2. White cell count greater than 15,000/ml.
  3. Increased sputum with a predominant organism on either Gram stain or culture of sputum.


NotesOtherwise treated with a standardised protocol including ICP monitoring, initial hyperventilation, hyperosmotic agents. Thiopentone in some.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Chacon 1987

MethodsPatients randomized 'by lottery method' to two groups.
Blinding not clear.


ParticipantsChildren admitted to hospital with severe head trauma, a Glasgow Coma Score of 7 or less and evidence of cerebral oedema on computerised tomography.


Interventions
  1. Dexamethasone - dose not stated.
  2. No dexamethasone.


OutcomesMortality at discharge.


NotesOther interventions - fluid restriction guided by central venous pressure and urine output, hyperventilation to PCO2 of 25 to 30 torr, head up position of 35 to 40 degrees.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Cooper 1979

MethodsRandom allocation using identical coded vials prepared and supplied by a drug company, who retained the code until the 6 month outcome assessment had been made.


ParticipantsAll patients with head injury admitted with a Grady Coma Grade of 3, 4 or 5. Glasgow Coma Scale also measured and in all except two patients GCS was 8 or less.
Patients were excluded due to inability to obtain informed consent, previous administration of steroids or arrival at hospital more than 6 hours after the injury.


Interventions
  1. High dose dexamethasone phosphate: 60mg initial dose, 24mg every 6 hours thereafter for 6 days.
  2. Low dose dexamethasone phosphate: 10mg initial dose, 4 mg every 6 hours thereafter for 6 days.
  3. Placebo (water, sodium bisulphite, methylparaben, propylparaben).


All doses were contained in the same volume of fluid.
Medication decreased gradually from day 7 and all were finished by day 11.
Children aged 16 or younger given weight related doses.


OutcomesGOS at 6 months after injury.


NotesCT scan used or diagnosis in most patients followed by operation for mass lesions. Other co-interventions not specifically described.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





CRASH 2005

MethodsStratified random allocation via central randomisation service or identical coded treatment packs.


ParticipantsAdults (16 or older) less than 8 hours after head trauma with GCS of 14 or less on admission to hospital.


Interventions
  1. High dose methylprednisolone for 48 hours. 2g over 1 hour, then 0.4g per hour for 48 hours.
  2. Identical placebo.


OutcomesMortality and GOS at 6 months.
Complications (admission to intensive care, gastrointestinal bleeding, infections, neurosurgical operation).


Notes


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Dearden 1986

MethodsRandomly allocated to receive treatment or placebo.


ParticipantsAll ages, patients with severe head injury (no definition given).
Exclusions were due to incorrect administration of steroid or placebo during the trial and those receiving steroids before admission.


Interventions
  1. Dexamethasone: initial dose 50mg IV (0.75mg/kg for children), days 1, 2, 3 100mg/day IV, day 4 50mg/day IV, day 5 25mg/day IV.
  2. Placebo.


OutcomesGlasgow Outcome Scale at 6 months after injury.
Duration of artificial ventilation.


NotesOther interventions guided by CT and ICP monitoring. Controlled hypocapeic ventilation and osmotic diuretics used to control ICP.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Faupel 1976

MethodsRandomly allocated using identical, coded vials containing the same volumes of clear solution.


ParticipantsAll adult patients with severe (not defined) closed head injury.
Exclusions were due to being a child (age cut off not given), impression fractures, missile injuries, imminent brain death and open head injuries. After randomization, 3 patients considered to be brain dead on angiography, one given steroids outside the trial and one who died of other injuries were excluded.


Interventions
  1. Dexamethasone: initial dose 100mg IV, then 100mg IM after 6 hours, then 4mg IM every 6 hours for 8 days, then tapered off by daily reduction of 4mg.
  2. Dexamethasone: initial dose 12mg IV, then 4mg IM every 6 hours for 8 days, then tapered off by daily reduction of 4mg.
  3. Placebo.


OutcomesDisability status scale at discharge from hospital.
Frequency of complications.


NotesMass lesions removed following angiography. Other interventions not specified.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Gaab 1994

MethodsPatients were randomized in blocks of 6. Stated to be double blind design.


ParticipantsAge 15 to 55 with moderate central nervous system injury (two or more of disturbed consciousness, eye opening to stimulation, no adequate verbal response, disorientation in time and place) or severe central nervous system injury (comatose on injury and/or on admission to hospital, no eye opening to painful stimuli). Patients also were required to have obvious neurological symptoms (e.g. hemiparesis or hemiplegia) or CT evidence of lesions requiring surgical intervention or hypodense area(s) in the brain.

Reasons for exclusion were: time to treatment was more than 3 hours, they had already had steroids, penetrating head injury, primary bulbar symptoms present, prognosis considered hopeless, known malignancy, peptic ulcer, tuberculosis, Cushing's syndrome, non traumatic neurological or psychiatric disease, spinal injury, suspected coagulation defects.


Interventions
  1. Dexamethasone: initial dose 200mg IV, then 300mg over next 3 hours, then 200mg 3 hours later, then 200mg 6 hourly for 8 doses.
  2. Placebo.


OutcomesModified GOS at 10 to 14 months (good recovery classified as fit for work or for rehabilitation, extra category indicating degree of care required for disabled).
GCS on day 5.
Interval to regaining consciousness.


NotesCo-interventions are not specified, but the study states that other care was not controlled.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Giannotta 1984

MethodsRandomly allocated to treatment or placebo using identical, coded vials. Code not broken until all outcomes had been collected.


ParticipantsPatients with blunt head trauma and a GCS of 8 or less 6 hours after the injury.
Exclusions were due to history of peptic ulcer, an undiagnosed or untreated medical condition or who had been taking steroids during the two weeks before injury, penetrating brain injuries, other injuries expected to cause rapid death, and pregnancy.


Interventions
  1. Methylprednisolone 30mg/kg IV every 6 hours for 2 doses, then 250mg IV every 6 hours for 8 doses, then tapering off over the next 8 days.
  2. Methylprednisolone 1.5mg/kg IV every 6 hours for 2 doses, then 25mg IV every 6 hours for 8 doses, then tapering off over 8 days.
  3. Placebo.


NB Patients randomized in 2:2:1 ratio for these groups.


OutcomesGlasgow Outcome Scale at 6 months.


NotesCT guided management. Controlled ventilation, cerebrospinal fluid drainage, osmotic diuretics and barbiturates were used to control ICP.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Grumme 1995

MethodsRandom allocation to treatment or control using identical vials.


ParticipantsPatients of all ages admitted with head injury. Excluded groups were those with contraindication to steroids (not specified), impaired level of consciousness not due to trauma and absence of relevant brain damage (not specified).


Interventions
  1. Triamcinolone acetonide: 200mg IV, then 40mg 8 hourly for 4 days, then 20mg 8 hourly for 4 days.
  2. Placebo.


OutcomesGOS at discharge from hospital and at approximately 1 year from the injury.


NotesCT was used to guide treatment. Osmotic diuretics, controlled ventilation and cerebrospinal fluid drainage were used to control ICP.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Hernesniemi 1979

MethodsRandom allocation using sealed opaque envelopes. Double blind.


ParticipantsAge 15 or above with severe closed brain injury.
Five exclusions; three not head injury, one 14 years old, one imminent death.


Interventions
  1. Betamethasone 100mg IV on admission, then 80mg/day IV for 7 days, then tapering off over further 7 days.
  2. Placebo.


OutcomesGlasgow Outcome Scale at 6 or 12 months.
Complications.


Notes


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Hoyt 1972

MethodsAssigned "sequentially in random order".


ParticipantsPatients with cranial trauma.


Interventions
  1. Dexamethasone, dose not stated.
  2. Triamcinolone, dose not stated.
  3. Placebo.


OutcomesProportion demonstrating a "marked improvement".


NotesUnable to contact author for further details.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Pitts 1980

Methods"Prospectively randomized" into three groups.


ParticipantsHead injured adults admitted to hospital who were comatose on admission or who lapsed into coma for six hours or more.


Interventions
  1. Dexamethasone: initially 24mg IV per day, for a maximum of 7 days, tapering of for the last 5.
  2. Dexamethasone: initially 16mg IV daily, for a maximum of 7 days, tapering off for the last 5.
  3. Placebo.


OutcomesGlasgow Outcome Scale at 6 months.
Gastrointestinal bleeding.
Infections (signs of pneumonia, wound infection, urinary infection, blood culture, CSF culture).


Notes


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Ransohoff 1972

MethodsStated to be "random steroid studies" and a double blind study of steroids against placebo.


ParticipantsCritically ill acute closed head injury patients without evidence of angiographic shift or significant clots, but with documented increase in intracranial pressure. Age not stated.


Interventions
  1. Methylprednisolone 125mg IV every 6 hours for 4 days, starting within 24 hours of admission.
  2. Placebo.


OutcomesDeath.
Complications (no data presented).


NotesAlso received fluid restriction.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Saul 1981

MethodsStates that 100 patients were "randomized into two groups of 50". One group received steroid, there was no placebo.


ParticipantsPatients admitted with craniocerebral trauma within 6 hours of injury. No other body systems injured, Glasgow Coma Scale 7 or less on admission. Average age 31 years.


Interventions
  1. 250mg methylprednisolone IV initially, then 125mg every 6 hours.
  2. Some in steroid group received dexamethasone in equivalent dose.
  3. No steroid, no placebo.


OutcomesGlasgow Outcome Scale at 6 months.


NotesAlso received mechanical hyperventilation and surgery if indicated.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Stubbs 1989

Methods"Randomized and double-blind" study. Allocation concealment not described.
Separate randomization for patients over and under 40 years old.


ParticipantsPatients were more than 6 years old with closed head trauma within the previous 48 hours and a GCS of 9 to 12. The first dose had to be administered within 6 hours of the GCS measurement. Exclusions were pregnancy, hypersensitivity to steroids and presence of infectious disease.


Interventions
  1. High dose MPSS: 30mg/kg IV twice in 6h, then 250mg IV every 6h until 48 h after the first dose. Then a tapering schedule: days 3 to 5 25mg IV/IM 6 hrly, day 6 10mg IV/IM 6 hrly, day 7 5mg IV/IM 6 hrly days 8 and 9 10mg IV/IM daily.
  2. Low dose MPSS: 1mg/kg IV twice in 6h followed by 25mg IV every 6h until day 6. Then the tapering schedule above.
  3. Placebo


OutcomesGlasgow Outcome Scale, Glasgow Coma Scale, Karnofsky Rating Scale at discharge, 3 and 6 months.
Complications listed.


NotesGlasgow Outcome Scale reported as mean score.
Attempting to locate authors for further information.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Tahara 1972

MethodsRandom allocation to one of three groups.


ParticipantsSeriously head injured.


Interventions
  1. Prednisolone 2,680mg over 2 weeks.
  2. Prednisolone 160mg on first day, tapering over two weeks, total dose 1,000mg.
  3. No steroid.


OutcomesNone reported.


NotesTrial of 100 participants; author contacted but unable to provide details.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear





Zagara 1987

MethodsRandomization by table into steroid or no therapy groups.


ParticipantsAverage age 29. Severe isolated head trauma with average GCS of 5.7 (sd 1.2) in one group and 5.8 (sd 1.2) in the other.


Interventions
  1. Dexamethasone 0.36mg/kg/day IV for 9 days.
  2. No steroid, no placebo mentioned.


OutcomesGlasgow Outcome Scale at 3 months. Nitrogen balance.


NotesAlso received mechanical hyperventilation, surgery if required, mannitol infusion and benzodiazepine sedation.


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?YesAdequate





Zarate 1995

Methods"Randomly allocated", no further details given.
60 patients, 30 in each group.


ParticipantsChildren admitted with head injury with a Glasgow Coma Scale of 9 to 15.


Interventions
  1. Corticosteroids - no details given.
  2. Symptomatic treatment.


OutcomesMortality at discharge.


Notes


Risk of bias

ItemAuthors' judgementDescription

Allocation concealment?UnclearUnclear

 CT: computerised tomography
GCS: Glasgow Coma Scale
CSF: Cerebrospinal Fluid
GOS: Glasgow Outcome Scale
ICP: intracranial pressure
IM: Intramuscular
IV: Intravenous
MPSS: methylprednisolone sodium succinate


 
Characteristics of excluded studies [ordered by study ID]

StudyReason for exclusion

Cheng 1991Randomised trial of high versus low dose steroids. No group with no steroids.

Fanconi 1988Judged to have inadequate allocation concealment after contact with authors.

Gobiet 1976Study was retrospective.

James 1979Allocation consisted of the first four patients being given no or low dose steroids and the next five given high dose steroids. There was therefore no concurrent control group and no concealment of allocation.

Robertson 1985Patients were alternately allocated.



 
Comparison 1. Any steroid administered in any dose against no steroid

Outcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size

 1 Death at end of follow up period17Risk Ratio (M-H, Fixed, 95% CI)Totals not selected

 2 Death or severe disability at the end of the study period10Risk Ratio (M-H, Fixed, 95% CI)Totals not selected

 3 Infections of any type510798Risk Ratio (M-H, Fixed, 95% CI)1.03 [0.99, 1.07]

 4 Major or significant gastrointestinal bleed1011302Risk Ratio (M-H, Fixed, 95% CI)1.23 [0.91, 1.67]